ABstrAct Purpose: Aortic Customize is a new concept for endovascular aortic aneurysm repair in which a non-polymerised elastomer is injected to fill the aneurysm sac around a balloon-catheter. Aim of this in-vitro study was to investigate the extent of aneurysm wall stress reduction by the presence of a compliant elastomer cuff. methods: A thin walled latex aneurysm (inner radius sac 18mm, inner radius neck 8mm), equipped with 12 tantalum markers, was attached to an in-vitro circulation model. Fluoroscopic roentgenographic stereo photogrammetric analysis (FRSA) was used to measure marker movement during 6 cardiac cycles. The radius of 3 circles drawn through the markers was measured before and after sac-filling. Wall movement was measured at different systemic pressures.
introduction
Endovascular aortic aneurysm repair (EVAR) has become a well established treatment of abdominal aortic aneurysms (AAA). Mortality after EVAR is significantly reduced compared to open repair. 1, 2 Despite these successes, EVAR has several drawbacks.
Complications and re-interventions caused mainly by endoleaks, endotension, stent-graft migration and device failure are of major concern. 3, 4 Lifelong follow-up is therefore needed because these complications can be associated with aneurysm rupture. Furthermore EVAR has anatomical restrictions. Manufacturers of commercial available EVAR-grafts state that an infrarenal aneurysm neck of at least 15mm is needed The two components of the elastomer are pumped in the excluded aneurysm. Excess blood is pushed out alongside the balloon. E. After the aneurysm is filled, the elastomer takes 5 minutes to cure. F. When the elastomer has cured, the endovascular balloon is deflated, leaving the aneurysm excluded with a new lumen.
to ensure a strong proximal seal, and tortuous anatomy is a (relative) contra-indication.
Timaran et al have shown that with 27% of AAA's the anatomy of the aneurysm makes it unsuitable for EVAR because of insufficient neck length, large neck diameter or severe angulation. 5 To overcome these disadvantages Aortic Customize was devised: a method of excluding the infrarenal aortic aneurysm using endovascular techniques to inject a biocompatible elastomer into the aneurysm sac ( Fig. 4.1) . The non-polymerised liquid elastomeric solution is used to fill the aneurysm sac around a balloon-catheter. An endoluminal mould excludes the aneurysm sac after in situ polymerisation. After balloon deflation a compliant elastomer cuff with a patent lumen is created.
Filling the aneurysm sac with an injectable biocompatible elastomer will realize a reduction in the wall stress and thereby a reduction in rupture risk, since aneurysm rupture occurs when the local wall stress exceeds the local wall strength. 6, 7 Aim of this in-vitro study is to measure the influence of aneurysm sac exclusion by an injectable biocompatible elastomer on the aneurysm wall-motion and thereby on the aneurysm wall stress.
Our hypothesis is that exclusion with an elastomer cuff will reduce wall-motion. This will, in combination with the augmentation of the aneurysmal wall, lead to a reduction of the aneurysmal wall-stress. 
mAteriAls And methods

set-up
An in-vitro circulation model (Fig. 4. 2), validated and described previously, was used. 8 A plexiglass box containing a latex aneurysm was connected to the in-vitro circulation model. 
compliance of aneurysm
The compliance (C) of the latex aneurysm was calculated by measuring the volume (dV)
needed to obtain a pressure increase (dP) in the isolated aneurysm as C=dV /dP. 9 The compliance was measured in the pressure region 30-160 mmHg. 
FrsA set-up
Wall motion [mm] of the aneurysm wall was measured by using fluoroscopic roentgenographic stereo photogrammetric analysis (FRSA). 10 FRSA is performed by calculating the point of intersection of two projection lines of a marker in space by using calibrated stereo roentgenographic imaging (Fig. 4.2) . 10 The Netherlands] to calculate the relative three-dimensional marker positions. 10, 12, 13 FRSA has an accuracy of 0.003 ±0.0019mm on marker motion detection. In the absence of a clotting system, a tie-rap was applied to prevent dissection between the elastomer and the latex aneurysm on both sides of the aneurysm.
measurements
The movement of the markers was measured in each of the aneurysms before and after excluding the aneurysm with the biocompatible elastomer. Through the markers 3 circles were fitted using routines, implemented in Matlab r2006B [The Mathworks, Natrick, USA]
( Fig. 4.3 
results compliance
The mean compliance of the aneurysm was 0.41 ml/mmHg (0.15-0.91 ml/mmHg) in the pressure range of 30-90 mmHg. The thin walled aneurysm nearly ruptured at pressures higher than 90 mmHg, as wall stress nearly exceeded wall strength. Therefore only compliance data from lower than 90 mmHg were available. In the circulation set-up, we were only able to measure the wall-movement up to a pressure of 90/60 mmHg (MAP 70mmHg) before treatment, as the aneurysm nearly ruptured at higher pressures.
radius
The FRSA measurements before sac-filling showed a clear increase in average radius of the proximal, middle and distal rings [3.3%-184.3%] ( Linear regression models showed significant increase in radius of the rings as a result of systematic pressure before sac-filling (Table 4 .2 & Fig. 4 
.4).
After treatment with the elastomer, the increase in radius of the circles declined to almost zero, but remained significant (Table 4 .2 & Fig. 4.4) . There was minimal to zero marker movement as pulsatility disappeared from the treated aneurysm (Fig. 4.5 ).
Wall stress
Wall stress calculations showed that before sac-filling the wall stress ranged from 7.5-13.3 N/cm 2 , while after sac-filling the wall stress was diminished to 0.5-1.2 N/cm 2 ( Fig. 4.4) . 
discussion
This study clearly demonstrates that filling an AAA sac with an elastomer results in a decrease of wall stress (Fig. 4.4) . After sac-filling, there was nearly no wall movement, not even with a pressure of ±220/140 mmHg (Fig. 4 .5 & 4.6).
Wall stress on the latex aneurysm was diminished as the radius did not increase and the wall thickness was increased due to filling of the aneurysm sac from 0.8mm to 18 mm at the middle ring. Calculations showed that the wall stress declined from 7.5-13.3 N/cm 2 to 0.5-1.2 N/cm 2 after sac-filling. It should be noted that these values are rough estimates as they are calculated from the mean arterial pressure, the measured radius and wall-thickness. During the experiments before treatment at a pressure of 90/60 mmHg, the local wall strength was exceeded at the site of the distal ring, leading to a rapid expansion of ±190% of its original size. This led to a pressure fall in the remaining aneurysm sac, which led to a decrease in the radius of the proximal ring (Fig. 4.4) . The slope of the linear regression model of the proximal ring of the untreated aneurysm is therefore remarkably lower than the slope of the middle and distal ring (Table 4 .1).
In the untreated aneurysm models, there was a large spread in measurements, which was due to the pulsatility of the aneurysm. After sac-filling, the spread is narrow as the elastomer absorbs the pulse waves (Fig. 4.4 & 4.5) .
The linear regression models show that before and after sac-filling there is a statistically significant increase in wall radius due to an increase in the systemic pressure (Table   4 .2). However the slopes of the models should be compared before and after sac-filling.
The linear regression models after sac-filling show a slope of 0.001 mm/mmHg, which is a nearly horizontal line (Table 4. 2). This means that with mean pressure increase of 100 mmHg, the radius of the aneurysm sac only increases 0.1mm. The slopes of the model before sac-filling are noticeably higher, as can be seen in Table 4 .2 and Fig. 4 .4.
The in-vitro experiment shows the large potential of this new treatment concept.
We appreciate the fact that every in-vitro experiment is a simplification of the in-vivo situation. The anatomy of the used aneurysm is simple, making its exclusion easy. The "aneurysmal wall" was made of latex and differs clearly from the in-vivo situation, whereby there is a high amount of intraluminal thrombus and other degenerative processes. However the use of in-vitro circulation models with latex aneurysms is, in spite of its limitations, a broadly accepted method to investigate physiological questions concerning aneurysm repair. 9, [22] [23] [24] [25] For this experiment we opted for direct injection in the aneurysm sac through a needle for practical reasons. The elastomer was pumped easily through the fill needle, filled the excluded aneurysm easily, leaving a perfect mould of the latex AAA with a straight patent lumen at the place of the balloon (Fig. 4.7) . Other, still unpublished, in-vitro experiments have shown to us that the elastomer can be pumped easily with a Another shortcoming might be the fact that we used the measured wall motion and the mean pressure to calculate the wall-stress (s). We used the formula s=pr/2t, as the sac of the latex aneurysm, resembled a sphere. The radius was only known on the site of the markers. However local wall stress could be higher or lower on different sites of the aneurysm. We choose to use this method as it was accurate and easy in use, while other, more complicated, methods such as infinite model stress analysis 26 were not available to us and other methods with fixed strain gauges are not very sensitive and may influence the measurements. 27 As this study was set-up as a proof of principle-experiment, we
were satisfied with approximations of wall-stress on a few sites of the aneurysm sac. The important finding is the difference in wall stress, before and after sac-filling (Fig. 4.4 ).
Potential limitations of treatment method
Before this technique can be used in-vivo, a few hurdles have to be taken. For the concept to work in-vivo, a blood-and pressure tight seal is preferable. In this in-vitro model the seal was obtained by applying a tie-rap on the outer-side of the latex aneurysm. Invivo, this potential cause of type I endoleaks can be treated by placing a Palmaz-stent, fixating the elastomer to the vessel wall.
When working with arterial embolic agents, there is always the risk of developing an embolus. An embolus in the lumbar arteries or in the inferior mesenteric artery might lead to paraplegia or colonic ischemia. However we expect that the elastomer will not travel far in the inferior mesenteric artery or lumbar arteries. In our extensive studies with the in-vitro model, emboli were not noted. The elastomer is more viscous and heavier then blood. The elastomer will press the blood out of the sac as it fills up the AAA. Due to the smaller diameter of the arteries, there will be a higher pressure in the side branches. Therefore the side branches will fill-up, when the whole sac is filled.
At that moment, the curing process of the elastomer is in full progress, the substance becomes even more viscous, and it will be very difficult for it to travel far in a pressurized small diameter vessel. Furthermore it should be noted that with the current EVAR-treatment of infrarenal AAA's, by which the inferior mesenteric artery is excluded as well, complications such as colon ischemia are seen seldom.
In non-thrombosed, large infrarenal aneurysms the needed volume of elastomer can be up to 400-500 ml. Theoretically, this might cause shear forces at the borders of the native aorta/ common iliac arteries and the elastomer lump and might increase the risk of kinking and obstruction. However we do not expect this to happen. The density of blood and thrombus is respectively 1.05 g/cm3 and 1.09 g/cm3. The density of our elastomer is 1.0167 g/cm3. This density is less than the density of blood and thrombus.
The shear forces at the borders of the native aorta before and after treatment with the elastomer should be in the same range. Hence we do no believe that the risk of kinking will increase.
All the potential shortcomings and their potential solutions remain speculation. Before in-vivo application, animal experiments must be done to see if these complications occur and how they can be treated at best.
To our knowledge this report is the first to describe the novel aneurysm treatment technique and no similar technique has been described in the literature. There has been word of an endoluminal stent-graft called "the Nellix-Sac", where the system is fixated in the aneurysm by filling a sac, which is incorporated in the graft, with a polymer.
However there has been no scientific article published about the treatment concept.
clinical relevance
Filling the aneurysm sac with an elastomer has a lot of potential advantages, compared to the current endovascular treatment options. To fill the sac with the biocompatible elastomer only a fill catheter with diameter of minimal 7 Fr and endovascular balloons need to be introduced transfemorally to the aneurysm sac. Most stent grafts need a minimal diameter of 14-22 Fr for access of the bulky delivery sheath, which makes many aneurysms with strong tortuosity or occlusive disease of the iliac arteries, ineligible for treatment. In theory, any AAA with a deviant anatomy will become treatable, as endovascular balloons will be available in different kinds of shape and configuration.
As stated above, future research must take place before this treatment option can be applied in-vivo. Animal experiments will take place to prevent embolic complications during the filling process and to investigate the short-and long-term effects of the presence of the elastomer in the aorta. Research on this novel treatment concept is in full progress and will be reported in the near future. 
